共 5 条
[1]
The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long- chain 3 - ketoacyl coenzyme A thiolase. Kantor PF,Lucien A,Kozak R,et al. Cire Research . 2000
[2]
The antiischemic effects and tolerability of trimetazidine in coronary diabetic patients A substudy from TRIMPOL-1. Szwed H,Sadowski Z,Pachocki R,et al. Cardiovascular Drugs . 1999
[3]
心脏能量学[M]. 第二军医大学出版社 , 殷仁富,陈金明主编, 2002